Coca-Cola

US · KO #37 by market cap Listed 1970

93.31 -0.11 -0.12%

Live - 5344 symbols - heartbeat 518s ago · 2026-10-20 10:50

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 5.53, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +1.87% YoY

Margins

Gross margin: 61.63%
Operating margin: 31.10%
Net margin: 27.34%

Key ratios & quality

Enterprise value: 431.16B
PEG ratio: 2.51
Altman Z-Score: 5.53

PEG uses trailing P/E against the 3-year net income growth rate (11.16%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	34.30B	37.27B	33.01B	38.66B	43.00B	45.75B	47.06B	47.94B
Gross profit	21.23B	22.65B	19.58B	23.30B	25.00B	27.23B	28.74B	29.54B
Selling & admin expenses	11.00B	12.10B	9.73B	12.14B	12.88B	13.97B	14.58B	14.52B
Research & development	--	--	--	--	--	--	--	--
Operating profit	9.79B	10.27B	9.73B	11.04B	12.04B	13.10B	14.02B	14.91B
Pretax profit	8.23B	10.79B	9.75B	12.43B	11.69B	12.95B	13.09B	16.00B
Tax	1.75B	1.80B	1.98B	2.62B	2.12B	2.25B	2.44B	2.86B
Net profit	6.48B	8.99B	7.77B	9.80B	9.57B	10.70B	10.65B	13.14B
Basic EPS	2	2	2	2	2	2	2	3
Diluted EPS	1.50	2.07	1.79	2.25	2.19	2.47	2.46	3.04

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Revenue	11.13B	12.54B	12.46B	11.82B	12.47B	13.38B
Gross profit	6.97B	7.82B	7.66B	7.10B	7.85B	8.42B
Selling & admin expenses	3.23B	3.47B	3.62B	4.20B	3.47B	3.72B
Research & development	--	--	--	--	--	--
Operating profit	3.72B	4.35B	4.01B	2.86B	4.37B	4.70B
Pretax profit	4.06B	4.80B	4.18B	2.96B	4.61B	5.48B
Tax	722.00M	993.00M	500.00M	646.00M	645.00M	1.04B
Net profit	3.34B	3.80B	3.68B	2.32B	3.97B	4.44B
Basic EPS	1	1	1	1	1	1
Diluted EPS	0.77	0.88	0.86	0.53	0.91	1.03

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	24.93B	20.41B	19.24B	22.55B	22.59B	26.73B	26.00B	31.04B
Cash & ST investments	16.12B	11.18B	10.91B	12.63B	11.63B	13.66B	14.57B	15.81B
Inventory	3.07B	3.38B	3.27B	3.41B	4.23B	4.42B	4.73B	4.43B
Total assets	83.22B	86.38B	87.30B	94.35B	92.76B	97.70B	100.55B	104.82B
Total current liabilities	28.78B	26.97B	14.60B	19.95B	19.72B	23.57B	25.25B	21.28B
Short-term debt	18.84B	15.25B	2.67B	4.65B	2.77B	6.52B	2.15B	3.37B
Long-term debt	25.38B	27.52B	40.13B	38.12B	36.38B	35.55B	42.38B	42.12B
Total liabilities	64,158,000,000.00	65,283,000,000.00	66,012,000,000.00	69,494,000,000.00	66,937,000,000.00	70,223,000,000.00	74,177,000,000.00	70,541,000,000.00
Total equity	19.06B	21.10B	21.28B	24.86B	25.83B	27.48B	26.37B	34.28B
Retained earnings	63.23B	65.86B	66.56B	69.09B	71.02B	73.78B	76.05B	80.38B

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Total current assets	26.18B	26.61B	27.25B	31.04B	30.39B	32.88B
Cash & ST investments	13.79B	14.30B	15.78B	15.81B	13.82B	16.37B
Inventory	5.10B	5.08B	4.80B	4.43B	4.73B	4.65B
Total assets	101.72B	104.33B	106.05B	104.82B	104.22B	107.92B
Total current liabilities	23.81B	21.94B	22.50B	21.28B	22.38B	25.20B
Short-term debt	5.58B	4.47B	4.24B	3.37B	4.83B	6.54B
Long-term debt	43.53B	44.98B	43.18B	42.12B	39.07B	37.00B
Total liabilities	73,962,000,000.00	74,151,000,000.00	72,778,000,000.00	70,541,000,000.00	68,483,000,000.00	69,607,000,000.00
Total equity	27.75B	30.18B	33.27B	34.28B	35.73B	38.32B
Retained earnings	77.19B	78.80B	80.31B	80.38B	82.03B	84.17B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	7.63B	10.47B	9.84B	12.63B	11.02B	11.60B	6.81B	7.41B
Depreciation & amortization	1.09B	1.37B	1.54B	1.45B	1.26B	1.13B	1.08B	1.05B
Free cash flow	6.08B	8.42B	8.67B	11.26B	9.53B	9.75B	4.74B	5.30B
Dividends paid	-6.64B	-6.85B	-7.05B	-7.25B	-7.62B	-7.95B	-8.36B	-8.78B
Stock buybacks / issuance	-436.00M	-91.00M	529.00M	591.00M	-581.00M	-1.75B	-1.05B	-433.00M
Ending cash balance	9.32B	6.74B	7.11B	10.03B	9.83B	9.69B	11.49B	11.01B

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Operating cash flow	-5.20B	3.81B	5.04B	3.76B	2.02B	5.52B
Depreciation & amortization	267.00M	279.00M	268.00M	236.00M	264.00M	266.00M
Free cash flow	-5.51B	3.37B	4.56B	2.87B	1.76B	5.10B
Dividends paid	-89.00M	-2.19B	-2.11B	-4.39B	-2.28B	-2.28B
Stock buybacks / issuance	-211.00M	-38.00M	-152.00M	-32.00M	-322.00M	-90.00M
Ending cash balance	8.42B	10.20B	13.36B	11.01B	10.57B	13.21B

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	37.79	49.61	40.48	46.20	40.51	42.82	41.86	45.97
ROA %	7.52	10.52	8.92	10.76	10.20	11.25	10.72	12.76
ROIC %	10.58	15.11	13.89	16.92	15.34	17.11	16.27	18.80
5-year avg ROE %	23.91	29.36	32.19	36.06	42.92	43.92	42.37	43.47
EBIT margin %	29.10	31.48	33.88	36.27	29.23	31.65	31.33	36.82
FCF / sales %	19.71	22.59	26.25	29.12	22.17	21.30	10.07	11.05
Current ratio	0.87	0.76	1.32	1.13	1.15	1.13	1.03	1.46
Quick ratio	0.69	0.56	0.96	0.81	0.77	0.72	0.72	0.89
Debt / assets	53.13	49.51	49.02	45.32	42.20	43.05	44.28	43.40
LT debt / equity	149.44	144.97	207.91	165.73	150.91	137.03	170.48	130.93
Interest coverage	10.09	12.40	7.78	8.78	14.25	9.48	8.90	10.67
Revenue CAGR (3Y) %	-8.17	-3.80	-3.04	4.06	4.89	11.49	6.78	3.69
Net income CAGR (3Y) %	-4.34	10.97	83.78	14.94	2.27	11.41	2.85	11.16
FCF CAGR (3Y) %	-8.65	8.83	17.88	22.80	4.24	3.99	-25.04	-17.80

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
ROE %	40.98	44.76	45.12	45.97	45.80	44.23
ROA %	10.72	11.85	12.28	12.76	13.31	13.49
ROIC %	15.78	17.43	18.18	18.80	18.82	18.92
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	31.84	35.54	36.71	36.82	36.92	37.50
FCF / sales %	--	--	11.69	11.05	25.49	28.52
Current ratio	1.10	1.21	1.21	1.46	1.36	1.30
Quick ratio	0.75	0.84	0.88	0.89	0.78	0.80
Debt / assets	48.28	47.39	44.71	43.40	42.11	40.35
LT debt / equity	166.13	157.34	138.18	130.93	116.15	102.35
Interest coverage	8.99	9.91	10.58	10.67	11.08	12.00
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

North America is the largest reported line at 40.42% of revenue, across 7 reported segments.
No single line clears half of revenue; Europe, Middle East & Africa (EMEA) is next at 24.22%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

North America40.42%

Europe, Middle East & Africa (EMEA)24.22%

Latin America13.74%

Asia Pacific11.82%

Bottling Investments11.41%

Corporate0.28%

Quote time 2026-10-20 10:50:16 · For reference only, not investment advice and not tailored to your situation.

Coca-Cola discussion 1 comments

dividend_since_college says:

September 18, 2026 at 4:49 pm

not exciting, never has been, dividend keeps growing every single year regardless of what the market does. this is the stock I literally never think about selling.

Reply